Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $32.9000 (-6.27%) ($32.5000 - $35.3000) on Mon. Sep. 26, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 43 | Latest Price | $32.9000(-6.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -4.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) ARKK(7%) PEJ(7%) VT(7%) XLF(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.095% in a week (0% probabilities). TLT(-6%) VIXM(-5%) GLD(-5%) GDX(-5%) VCSH(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 0 () | Intraday Trend | -6.8% | | | |
|
Resistance Level | $36.99 | 5 Day Moving Average | $35.51(-7.35%) | 10 Day Moving Average | $36.32(-9.42%) | 20 Day Moving Average | $36.99(-11.06%) | To recent high | -24% | To recent low | 0% | Market Cap | $648m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |